McKesson Corp (MCK) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/mckesson-corp-mck-financial-n-strategic-swot-analysis-review_en.gif)
McKesson Corp (MCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
McKesson Corp (McKesson) distributes medicines and provides healthcare services and information technology solutions. The company distributes pharmaceuticals, medical equipment, and health and skincare products. It also offers pharmacy management software, pharmacy operations, pharmacy automation solutions, drug purchasing management, pharmacy group purchasing, pharmacy claims reimbursement, audit risk mitigation, patient adherence and wellness, alternate site pharmacy solutions, and pharmacy consulting & technology. McKesson offers pharmaceutical and specialty solutions to retail, hospital, alternate site pharmacies, and participating pharmacies that operate under franchise arrangements and brand partnership; medical-surgical solutions to healthcare providers in the US. The company offers prescription technology solutions to retail pharmacies in Canada. It has operations in the US, Canada, the UK, Germany, Norway, and Ireland. McKesson is headquartered in Irving, Texas, the US.
McKesson Corp Key Recent Developments
Jun 04,2021: First phase results of MYLUNG Consortium provide historical view of biomarker testing patterns and identify data gaps for ongoing prospective research
May 26,2021: McKesson joins Lansing region MedTech industry, invests in new delhi township facility
May 06,2021: McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
May 06,2021: McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Apr 19,2021: McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
McKesson Corp (McKesson) distributes medicines and provides healthcare services and information technology solutions. The company distributes pharmaceuticals, medical equipment, and health and skincare products. It also offers pharmacy management software, pharmacy operations, pharmacy automation solutions, drug purchasing management, pharmacy group purchasing, pharmacy claims reimbursement, audit risk mitigation, patient adherence and wellness, alternate site pharmacy solutions, and pharmacy consulting & technology. McKesson offers pharmaceutical and specialty solutions to retail, hospital, alternate site pharmacies, and participating pharmacies that operate under franchise arrangements and brand partnership; medical-surgical solutions to healthcare providers in the US. The company offers prescription technology solutions to retail pharmacies in Canada. It has operations in the US, Canada, the UK, Germany, Norway, and Ireland. McKesson is headquartered in Irving, Texas, the US.
McKesson Corp Key Recent Developments
Jun 04,2021: First phase results of MYLUNG Consortium provide historical view of biomarker testing patterns and identify data gaps for ongoing prospective research
May 26,2021: McKesson joins Lansing region MedTech industry, invests in new delhi township facility
May 06,2021: McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
May 06,2021: McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Apr 19,2021: McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
McKesson Corp - Key Facts
McKesson Corp - Key Employees
McKesson Corp - Key Employee Biographies
McKesson Corp - Major Products and Services
McKesson Corp - History
McKesson Corp - Company Statement
McKesson Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
McKesson Corp - Business Description
Business Segment: International
Overview
Performance
Key Stats
Business Segment: Medical-Surgical Solutions
Overview
Performance
Performance
Business Segment: Prescription Technology Solutions
Overview
Performance
Business Segment: US Pharmaceutical
Overview
Performance
Key Stats
R&D Overview
McKesson Corp - Corporate Strategy
McKesson Corp - SWOT Analysis
SWOT Analysis - Overview
McKesson Corp - Strengths
McKesson Corp - Weaknesses
McKesson Corp - Opportunities
McKesson Corp - Threats
McKesson Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
McKesson Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 04, 2021: First phase results of MYLUNG Consortium provide historical view of biomarker testing patterns and identify data gaps for ongoing prospective research
May 26, 2021: McKesson joins Lansing region MedTech industry, invests in new delhi township facility
May 06, 2021: McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
May 06, 2021: McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Apr 19, 2021: McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
Apr 01, 2021: The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology
Apr 01, 2021: McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
Mar 25, 2021: McKesson approved as QCDR for 2021 MIPS Program Year
Mar 22, 2021: Ontada Appoints Susan Shiff, Ph.D., MBA, as President
Mar 18, 2021: McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
McKesson Corp - Key Facts
McKesson Corp - Key Employees
McKesson Corp - Key Employee Biographies
McKesson Corp - Major Products and Services
McKesson Corp - History
McKesson Corp - Company Statement
McKesson Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
McKesson Corp - Business Description
Business Segment: International
Overview
Performance
Key Stats
Business Segment: Medical-Surgical Solutions
Overview
Performance
Performance
Business Segment: Prescription Technology Solutions
Overview
Performance
Business Segment: US Pharmaceutical
Overview
Performance
Key Stats
R&D Overview
McKesson Corp - Corporate Strategy
McKesson Corp - SWOT Analysis
SWOT Analysis - Overview
McKesson Corp - Strengths
McKesson Corp - Weaknesses
McKesson Corp - Opportunities
McKesson Corp - Threats
McKesson Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
McKesson Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 04, 2021: First phase results of MYLUNG Consortium provide historical view of biomarker testing patterns and identify data gaps for ongoing prospective research
May 26, 2021: McKesson joins Lansing region MedTech industry, invests in new delhi township facility
May 06, 2021: McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
May 06, 2021: McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Apr 19, 2021: McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
Apr 01, 2021: The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology
Apr 01, 2021: McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
Mar 25, 2021: McKesson approved as QCDR for 2021 MIPS Program Year
Mar 22, 2021: Ontada Appoints Susan Shiff, Ph.D., MBA, as President
Mar 18, 2021: McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
McKesson Corp, Key Facts
McKesson Corp, Key Employees
McKesson Corp, Key Employee Biographies
McKesson Corp, Major Products and Services
McKesson Corp, History
McKesson Corp, Other Locations
McKesson Corp, Subsidiaries
McKesson Corp, Key Competitors
McKesson Corp, Ratios based on current share price
McKesson Corp, Annual Ratios
McKesson Corp, Annual Ratios (Cont...1)
McKesson Corp, Annual Ratios (Cont...2)
McKesson Corp, Interim Ratios
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
McKesson Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
McKesson Corp, Key Facts
McKesson Corp, Key Employees
McKesson Corp, Key Employee Biographies
McKesson Corp, Major Products and Services
McKesson Corp, History
McKesson Corp, Other Locations
McKesson Corp, Subsidiaries
McKesson Corp, Key Competitors
McKesson Corp, Ratios based on current share price
McKesson Corp, Annual Ratios
McKesson Corp, Annual Ratios (Cont...1)
McKesson Corp, Annual Ratios (Cont...2)
McKesson Corp, Interim Ratios
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
McKesson Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
McKesson Corp, Performance Chart (2017 - 2021)
McKesson Corp, Ratio Charts
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
McKesson Corp, Performance Chart (2017 - 2021)
McKesson Corp, Ratio Charts
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021